Coronavirus Disease 2019 (COVID-19) | FDA

Coronavirus Disease 2019 (COVID-19) | FDA

Coronavirus (COVID-19) Update: Daily Roundup August 18, 2020

The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: The FDA is providing two new flowcharts and supporting information on respirators: For health care providers and facilities: Considerations for Selecting Respirators for Your Health Care Facility For manufacturers and distributors: Manufacturing and Distributing Respirators for Health Care Use in the United States Under an Existing Emergency Use Authorization (EUA) During the COVID-19 Pandemic The FDA has updated its COVID-19 Resources for Health Professionals page to include the CURE ID app. CURE ID allows clinicians to quickly and easily share their experiences treating COVID-19 patients and patients with other difficult-to-treat infectious diseases. Testing updates: To date, the FDA has currently authorized 217 tests under EUAs; these include 176 molecular tests, 39 antibody tests, and 2 antigen tests.